Uncategorized
Anachronistic health care policies, bureaucracy limit access to therapy for macular disease in Italy
Due to insufficient funding, dysfunctional organization and bureaucratic redundancy, patients with age-related macular degeneration and other macular diseases are often undermonitored and undertreated in Italy. A recent survey carried out in one of the wealthiest and best served regions of northern Italy showed that the average number of injections administered per patient per year is only three.“As president of the Italian Society of Ophthalmology (SOI), I have informed the Italian Medicines Agency (AIFA) and the Healthcare Commission that we are in a critical situation of not being able to provide (Read more...)